Sign in

CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company

Vistagen Therapeutics, Inc.

Sign in to watch
Ticker
VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NV
Entity type
operating
EIN
205093315
Phone
650-577-3600
Business address
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
Excaliber Enterprises, Ltd.
  1. 4 Grant or award Chief Operating Officer acquired 2,671 shares (grant or award)
  2. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 3,592 shares (grant or award)
  3. 4 Grant or award CHF CORP DEVEL OFF, GEN COUNS acquired 4,854 shares (grant or award)
  4. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 4,854 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award CHF CORP DEVEL OFF, GEN COUNS acquired 167 shares (grant or award)
  16. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 167 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 3 of 15 · 282 filings